- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00066040
Prevention of Transmission of Bacteria That Cause Cavities From Mothers to Their Children
November 1, 2022 updated by: New York University
Prevention of Transmission of Mutans Streptococci From Mother to Child
The purpose of this study is to control the levels of bacteria that causes cavities in mothers by a combination of treatments that include fluoride and chlorhexidine varnishes and xylitol-chewing gum before the appearance of teeth in the mouth of their children.
By doing that we expect to reduce the acquisition of the bacteria that causes cavities (the mutans streptococci) by the children which in turn will reduce the development of cavities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Dental decay is the most prevalent affliction in children worldwide.
In recent years the occurrence of dental decay has declined dramatically in many industrialized countries subsequent to the widespread availability of fluoride in the water supply and dentifrices.
However, in newly industrialized countries such as Brazil, the occurrence of decay is still high, especially among lower income groups.
The mutans streptococci (MS) have been convincingly associated with human dental decay and clinical protocols, which seek to reduce the levels of MS invariably, thus resulting in a significant reduction in decay.
One of the most important observations from these studies is the possibility that decay and the establishment of MS can be reduced and/or prevented in young children by treating those mothers who are highly infected with MS prior to the eruption of the primary teeth.
Other studies indicate that if the MS does not colonize the primary teeth in the first year after their eruption, they are likely to remain caries free during the following years.
These findings indicate that delaying the colonization of the MS in the primary dentition may prevent dental decay.
The ideal population for such a study can be found in communities without water fluoridation, with a high level of unmet dental care, and who would have frequent access to sugar.
Populations in many newly industrialized countries would meet these qualifications.
However, it is difficult to perform an interceptive study, such as preventing the transmission of the MS from mother to infant in such countries, as the local dental community has neither the financial and physical resources nor the trained dental personnel.
We have found an exception to this in the city of Bauru, Sao Paulo, Brazil.
This community of 250,000 residents is situated in the sugar cane growing region of Brazil and boasts the leading dental school in South and Central America.
In the investigation described, we will collaborate with the Bauru investigators in a longitudinal randomized clinical trial with the following specific aims: 1) to determine whether the salivary levels of the MS can be reduced in mothers of young infants by an intervention program consisting of restorations, topical fluorides, the use of xylitol chewing gum, chlorhexidine varnishes and oral hygiene instructions; 2) to determine whether this intervention reduces or delays the acquisition of MS in the infants and whether this in turn reduces the subsequent caries incidence in children
Study Type
Interventional
Enrollment
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sao Paulo
-
Bauru,, Sao Paulo, Brazil
- University of Pittsburgh-Univesidade de Dao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 months to 35 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion/Exclusion Criteria:
- Mother
- 20 teeth
- Medically healthy
- First-time mother
- High levels of the mutans streptococci
- No fluoride exposure in the previous 6 months.
- Infant
- Medically healthy
- No cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: DOUBLE
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2001
Primary Completion (ACTUAL)
January 1, 2006
Study Completion (ACTUAL)
January 1, 2006
Study Registration Dates
First Submitted
August 1, 2003
First Submitted That Met QC Criteria
August 4, 2003
First Posted (ESTIMATE)
August 5, 2003
Study Record Updates
Last Update Posted (ACTUAL)
November 3, 2022
Last Update Submitted That Met QC Criteria
November 1, 2022
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Demineralization
- Tooth Diseases
- Dental Caries
- Physiological Effects of Drugs
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Protective Agents
- Cariostatic Agents
- Disinfectants
- Fluorides
- Chlorhexidine
- Fluorides, Topical
- Sodium fluoride topical preparation
- Chlorhexidine, thymol drug combination
Other Study ID Numbers
- NIDCR-13534
- R01DE013534 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caries, Dental
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Universidad Autonoma de Baja CaliforniaNot yet recruitingDental Caries in Children | Caries, Dental | Caries; DentinMexico
Clinical Trials on Cervitec chlorhexidine varnish
-
Rosa Moreno LopezIvoclar Vivadent AGWithdrawnCaries | Periodontal DiseaseUnited Kingdom
-
Gül KeskinAlanya Alaaddin Keykubat UniversityRecruitingDental Caries in Children | Dental CariesTurkey (Türkiye)
-
Khyber Medical University PeshawarGandhara UniversityCompletedTooth Demineralization | Dental Plaque | Gingival HyperplasiaPakistan
-
Cairo UniversityCompleted
-
University of ZagrebNot yet recruitingPlaque, Dental | White Spot Lesion | Dental Plaque Induced Gingivitis
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
Universidad Autonoma de San Luis PotosíUnknown
-
Ivoclar Vivadent AGNot yet recruitingDentin Hypersensitivity | Dentin Desensitizing AgentsLiechtenstein
-
Pakistan Institute of Medical SciencesRecruitingDental Plaque Accumulation | Fluoride Varnishes | NanoparticlesPakistan